Novel Transcriptional Factors Regulating Cancer Stemness
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Molecular Cancer Biology".
Deadline for manuscript submissions: closed (31 December 2023) | Viewed by 1513
Special Issue Editor
Special Issue Information
Dear Colleagues,
Cancer stemness, referring to the stem-cell-like phenotypes of cancer cells, plays an essential role in tumor initiation, progression, and metastasis, as well as various malignant phenotypes, including therapeutic resistance, angiogenesis, and immune evasion. Preclinical evidence has supported that targeting cancer stemness may be considered a key element in cancer treatment for more effective inhibition of tumor growth and recurrence.
Cancer stemness is regulated by a transcriptional network relying on transcription factors to transfer and amplify oncogenic signals. A more comprehensive understanding of transcription factors in this network will facilitate the development of therapeutic strategies targeting cancer stemness. This Special Issue will publish novel discoveries of transcription factors regulating cancer stemness, and their associated molecular mechanisms and potential targeted strategies.
This Special Issue will highlight the latest discoveries in the field of transcriptional regulation of cancer stemness, with a particular focus on novel mechanistic insights and therapeutic development.
Dr. Mingyao Ying
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cancer stem-like cells
- stemness
- tumor heterogeneity
- transcriptional regulation
- epigenetics
- targeted therapy